Back to mobile site

More on SABS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.3 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

SAB Biotherapeutics (NQ:SABS)
Delayed: 3.33 -0.05 (1.48%)
Prev. Close $3.38  
Open$3.40 
52 Wk High$ 
52 Wk Low$ 
Day High$3.55 
Day Low$3.33 
P/E N/A  
EPS$ 
Volume356,433 

Friends, Peers and Foes (?): SABSW EBS (more...)

May 22, 2026 05:08 AM Citi Starts SAB Biotherapeutics (SABS) at Buy
May 20, 2026 03:18 AM Jefferies Starts SAB Biotherapeutics (SABS) at Buy
May 15, 2026 04:00 PM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: PERCEPTIVE ADVISORS LLC
May 15, 2026 11:18 AM Form SCHEDULE 13G SAB Biotherapeutics, Filed by: Caligan Partners LP
May 15, 2026 06:36 AM Form SCHEDULE 13G SAB Biotherapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 12, 2026 12:07 PM SAB Biotherapeutics (SABS) PT Raised to $10 at H.C. Wainwright
May 12, 2026 07:36 AM Form 10-Q SAB Biotherapeutics, For: Mar 31
May 12, 2026 07:30 AM SAB Biotherapeutics reports Q1 2026 results, enrollment progress
May 12, 2026 07:30 AM SAB BIO Reports Q1 2026 Financial Results and Recent Business Highlights
May 5, 2026 08:30 AM SAB BIO to Host First Quarter 2026 Financial Results Conference Call and Webcast on May 12, 2026, 08:30 AM ET
View All Articles

Entities mentioned with SABS

View All Entities